Literature DB >> 28100496

Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.

Puja Van Epps1,2, Terrence Tumpey3, Melissa B Pearce3, Hana Golding4, Patricia Higgins5,6, Thomas Hornick5,2, Christopher Burant5,6, Brigid M Wilson5, Richard Banks5, Stefan Gravenstein7, David H Canaday5,2.   

Abstract

Both preexisting immunity to influenza and age have been shown to be correlates of influenza vaccine responses. Frailty, an indicator of functional impairment in older adults, was also shown in one study to predict lower influenza vaccine responses among nonveterans. In the current study, we aimed to determine the associations between frailty, preexisting immunity, and immune responses to influenza vaccine among older veterans. We studied 117 subjects (age range, 62 to 95 years [median age, 81 years]), divided into three cohorts based on the Fried frailty test, i.e., nonfrail (NF) (n = 23 [median age, 68 years]), prefrail (n = 50 [median age, 80 years]), and frail (n = 44 [median age, 82 years]), during the 2010-2011 and 2011-2012 influenza seasons. Subjects received the seasonal trivalent inactivated influenza vaccine, and baseline and postvaccination samples were obtained. Anti-influenza humoral immunity, as measured by hemagglutination inhibition (HI) and microneutralization assays, was measured for influenza B, A(H1N1)pdm09, and A(H3N2) viruses. Postvaccination titers were not different between frail and NF subjects overall in this older subset of veterans. However, preexisting HI titers were strongly correlated with postvaccination titers among all functional status groups. When microneutralization titers were compared, the association between preexisting immunity and vaccine responses varied by frailty status, with the strongest correlation being observed for the NF group. In conclusion, preexisting immunity rather than frailty appeared to predict postvaccination titers in this older veteran cohort.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Frailty; influenza vaccines

Mesh:

Substances:

Year:  2017        PMID: 28100496      PMCID: PMC5339642          DOI: 10.1128/CVI.00498-16

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  41 in total

1.  Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus.

Authors:  S Grund; O Adams; S Wählisch; B Schweiger
Journal:  J Virol Methods       Date:  2010-12-10       Impact factor: 2.014

2.  Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses.

Authors:  Adrian J Reber; Jin Hyang Kim; Renata Biber; H Keipp Talbot; Laura A Coleman; Tatiana Chirkova; F Liaini Gross; Evelene Steward-Clark; Weiping Cao; Stacie Jefferson; Vic Veguilla; Eric Gillis; Jennifer Meece; Yaohui Bai; Heather Tatum; Kathy Hancock; James Stevens; Sarah Spencer; Jufu Chen; Paul Gargiullo; Elise Braun; Marie R Griffin; Maria Sundaram; Edward A Belongia; David K Shay; Jacqueline M Katz; Suryaprakash Sambhara
Journal:  Open Forum Infect Dis       Date:  2015-04-15       Impact factor: 3.835

3.  Impact of influenza vaccination on seasonal mortality in the US elderly population.

Authors:  Lone Simonsen; Thomas A Reichert; Cecile Viboud; William C Blackwelder; Robert J Taylor; Mark A Miller
Journal:  Arch Intern Med       Date:  2005-02-14

Review 4.  Immunosenescence and vaccine failure in the elderly.

Authors:  Beatrix Grubeck-Loebenstein; Silvia Della Bella; Anna Maria Iorio; Jean-Pierre Michel; Graham Pawelec; Rafael Solana
Journal:  Aging Clin Exp Res       Date:  2009-06       Impact factor: 3.636

5.  Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults.

Authors:  Xu Yao; Robert G Hamilton; Nan-ping Weng; Qian-Li Xue; Jay H Bream; Huifen Li; Jing Tian; Shu-Hui Yeh; Barbara Resnick; Xiyan Xu; Jeremy Walston; Linda P Fried; Sean X Leng
Journal:  Vaccine       Date:  2011-05-10       Impact factor: 3.641

6.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

Review 7.  Aging and impaired immunity to influenza viruses: implications for vaccine development.

Authors:  Wai Ming Liu; Bernard A M van der Zeijst; Claire J P Boog; Ernst C Soethout
Journal:  Hum Vaccin       Date:  2011-01-01

8.  Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11.

Authors:  Mark G Thompson; Allison Naleway; Alicia M Fry; Sarah Ball; Sarah M Spencer; Sue Reynolds; Sam Bozeman; Min Levine; Jacqueline M Katz; Manjusha Gaglani
Journal:  Vaccine       Date:  2016-02-10       Impact factor: 3.641

9.  Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.

Authors:  Jung Pu Hsu; Xiahong Zhao; Mark I-Cheng Chen; Alex R Cook; Vernon Lee; Wei Yen Lim; Linda Tan; Ian G Barr; Lili Jiang; Chyi Lin Tan; Meng Chee Phoon; Lin Cui; Raymond Lin; Yee Sin Leo; Vincent T Chow
Journal:  BMC Infect Dis       Date:  2014-07-28       Impact factor: 3.090

10.  Microneutralization assay titres correlate with protection against seasonal influenza H1N1 and H3N2 in children.

Authors:  Chris P Verschoor; Pardeep Singh; Margaret L Russell; Dawn M E Bowdish; Angela Brewer; Louis Cyr; Brian J Ward; Mark Loeb
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

View more
  14 in total

1.  Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage.

Authors:  Shahzma Merani; George A Kuchel; Alison Kleppinger; Janet E McElhaney
Journal:  Exp Gerontol       Date:  2017-09-27       Impact factor: 4.032

2.  The effect of frailty on HAI response to influenza vaccine among community-dwelling adults ≥ 50 years of age.

Authors:  Krissy K Moehling; Mary Patricia Nowalk; Chyongchiou Jeng Lin; Marnie Bertolet; Ted M Ross; Chalise E Carter; Michael Susick; Sean G Saul; A Murat Kaynar; Joyce T Bromberger; Richard K Zimmerman
Journal:  Hum Vaccin Immunother       Date:  2017-12-20       Impact factor: 3.452

Review 3.  Roadmap for Sex-Responsive Influenza and COVID-19 Vaccine Research in Older Adults.

Authors:  Janna R Shapiro; Rosemary Morgan; Sean X Leng; Sabra L Klein
Journal:  Front Aging       Date:  2022-02-11

4.  The Burden of Frailty Among U.S. Veterans and Its Association With Mortality, 2002-2012.

Authors:  Ariela R Orkaby; Lisa Nussbaum; Yuk-Lam Ho; David Gagnon; Lien Quach; Rachel Ward; Rachel Quaden; Enzo Yaksic; Kelly Harrington; Julie M Paik; Dae H Kim; Peter W Wilson; J Michael Gaziano; Luc Djousse; Kelly Cho; Jane A Driver
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-07-12       Impact factor: 6.053

Review 5.  Mechanisms underlying T cell ageing.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Nat Rev Immunol       Date:  2019-06-11       Impact factor: 53.106

6.  Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.

Authors:  Vipin Narang; Yanxia Lu; Crystal Tan; Xavier F N Camous; Shwe Zin Nyunt; Christophe Carre; Esther Wing Hei Mok; Glenn Wong; Sebastian Maurer-Stroh; Brian Abel; Nicolas Burdin; Michael Poidinger; Paul Anantharajah Tambyah; Nabil Bosco; Lucian Visan; Tze Pin Ng; Anis Larbi
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

Review 7.  Considerations for a Respiratory Syncytial Virus Vaccine Targeting an Elderly Population.

Authors:  Laura M Stephens; Steven M Varga
Journal:  Vaccines (Basel)       Date:  2021-06-09

Review 8.  The immune response to influenza in older humans: beyond immune senescence.

Authors:  Janet E McElhaney; Chris P Verschoor; Melissa K Andrew; Laura Haynes; George A Kuchel; Graham Pawelec
Journal:  Immun Ageing       Date:  2020-05-07       Impact factor: 6.400

9.  Healthy elderly Singaporeans show no age-related humoral hyporesponsiveness nor diminished plasmablast generation in response to influenza vaccine.

Authors:  Xavier Camous; Lucian Visan; Crystal Tan Tze Ying; Brian Abel; Ma Shwe Zin Nyunt; Vipin Narang; Michael Poidinger; Christophe Carre; Sanie Sesay; Nabil Bosco; Nicolas Burdin; Paul Anantharajah Tambyah; Ng Tze Pin; Anis Larbi
Journal:  Immun Ageing       Date:  2018-11-12       Impact factor: 6.400

Review 10.  Recent advances in influenza vaccines.

Authors:  Graham Pawelec; Janet McElhaney
Journal:  F1000Res       Date:  2020-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.